Company · founded 2007

3DT Holdings (United States)

Indianapolis, United States · 3dtholdings.com

Manage this page

Citations, last 5 years: 42
Works, last 5 years: 19
h-index: 14
Scientists listed: 2
Grants since 2016: 26

Grants received

2025–2027 · research · R44

Software-guided Operative Planning of MitraClip Placement

Julius Matteo Guccione · 3DT Holdings (United States) · funded by National Institutes of Health

$1.1M

2024–2026 · research · R43

Low Profile Transcatheter Aortic Valve Implant

Xiaomei Guo · 3DT Holdings (United States) · funded by National Institutes of Health

$497.4kCardiac Valve Diseases and Treatments

2024–2025 · research · R44

Software-guided Operative Planning of MitraClip Placement

Julius Matteo Guccione · 3DT Holdings (United States) · funded by National Institutes of Health

$481kCardiac Valve Diseases and Treatments

2024–2025 · research · R43

Novel Tracheostoma Device

Terry Hubbard · 3DT Holdings (United States) · funded by National Institutes of Health

$400k

2024–2025 · research · R43

Software Tool for Optimization of CRT

Julius Matteo Guccione · 3DT Holdings (United States) · funded by National Institutes of Health

$293.7kCardiac pacing and defibrillation studies

2024–2026 · research · R43

Novel Stabilization Catheter for His Pacing Lead Implant

William Combs · 3DT Holdings (United States) · funded by National Institutes of Health

$437.5kCardiac pacing and defibrillation studies

2021 · research · R44

Biomechatronics Device for Diagnosis/Therapy of Anorectal Disorders

William Combs · 3DT Holdings (United States) · funded by National Institutes of Health

$186k

2021–2023 · research · R44

Biomechatronics Device for Diagnosis/Therapy of Anorectal Disorders

William Combs · 3DT Holdings (United States) · funded by National Institutes of Health

$1.1M

2021–2024 · research · R44

Biomechatronics Device for Diagnosis/Therapy of Anorectal Disorders

William Combs · 3DT Holdings (United States) · funded by National Institutes of Health

$854.1k

2020–2022 · research · R43

New Access Kit for Lymphatic Interventions

Ghassan S Kassab · 3DT Holdings (United States) · funded by National Institutes of Health

$339.9kLymphatic Disorders and Treatments

2020–2023 · research · R43

Left Atrial Appendage Inversion to Prevent Stroke

Ghassan S Kassab · 3DT Holdings (United States) · funded by National Institutes of Health

$365.7kAtrial Fibrillation Management and Outcomes

2020–2023 · research · R43

Vasodilation Needle for Trans-Radial Access

William Combs · 3DT Holdings (United States) · funded by National Institutes of Health

$376.6kVascular Procedures and Complications

2019–2022 · research · R43

HLS-Diagnostic Balloon in Novel Venous Disease Model

William Combs · 3DT Holdings (United States) · funded by National Institutes of Health

$364.2kDiagnosis and Treatment of Venous Diseases

2019–2021 · research · R43

Small Peripheral Vessel Graft

Terry Hubbard · 3DT Holdings (United States) · funded by National Institutes of Health

$325.5k

2019–2022 · research · R43

Novel Leaflet Biomaterial for Pulmonary Artery Valve

Terry Hubbard · 3DT Holdings (United States) · funded by National Institutes of Health

$447.2k

2019–2022 · research · R43

Real-Time Virtual Assessment of MitraClip Placement

Yaghoub Dabiri · 3DT Holdings (United States) · funded by National Institutes of Health

$289.7kCardiac Valve Diseases and Treatments

2018–2020 · research · R43

Novel Biological Tissue for Vascular Patch

Ghassan S Kassab · 3DT Holdings (United States) · funded by National Institutes of Health

$419.1kTissue Engineering and Regenerative Medicine

2017–2019 · research · R43

Novel Fecobionics Device for Diagnosis of Anorectal Disorders

William Combs · 3DT Holdings (United States) · funded by National Institutes of Health

$259kAnorectal Disease Treatments and Outcomes

2017–2018 · research · R43

HLS-Animal Model and Treatment of Chronic Venous Insufficiency

Ghassan S Kassab · 3DT Holdings (United States) · funded by National Institutes of Health

$359.1kDiagnosis and Treatment of Venous Diseases

2017–2019 · research · R44

Suction Device for Control and Accuracy of Transseptal Access

Ghassan S Kassab · 3DT Holdings (United States) · funded by National Institutes of Health

$808.6k

2017–2021 · research · R44

Suction Device for Control and Accuracy of Transseptal Access

Ghassan S Kassab · 3DT Holdings (United States) · funded by National Institutes of Health

$1.2M

2016–2018 · research · R43

Device for Treatment of Cardiac No-Option Patients

Kyle Bates · 3DT Holdings (United States) · funded by National Institutes of Health

$285.4kCardiac Ischemia and Reperfusion

2016–2020 · research · R44

Device for Treatment of Cardiac No-Option Patients

Terry Hubbard · 3DT Holdings (United States) · funded by National Institutes of Health

$1.4MCardiac Ischemia and Reperfusion

2016–2022 · research · R44

Device for Treatment of Cardiac No-Option Patients

Terry Hubbard · 3DT Holdings (United States) · funded by National Institutes of Health

$991.9kCardiac Ischemia and Reperfusion

2014–2021 · research · R44

Mild Hypothermia Catheter for Reperfusion Injury

Terry Hubbard · 3DT Holdings (United States) · funded by National Institutes of Health

$1.1M

2013–2020 · research · R44

Coronary Post-Dilatation Catheter

William Combs · 3DT Holdings (United States) · funded by National Institutes of Health

$781.4kCoronary Interventions and Diagnostics